–
Entrada Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.1
FY22:
−97.2
FY23:
−3.16
FY24:
47.0
FY25:
−158
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.0
FY22:
−95.4
FY23:
−0.32
FY24:
50.8
FY25:
−154
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.2
FY22:
−94.6
FY23:
12.1
FY24:
66.5
FY25:
−143
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.2
FY22:
−94.6
FY23:
−6.69
FY24:
65.6
FY25:
−144
All amounts in millions USD